TGFB1 and cancer: Notably, high TGF-β1 expression was an independent predictor of worse overall survival (hazard ratio 1.565, p = 0.041) and correlated with cancer-specific death (37.1% in TGF-β1-high patients, p = 0.043), underscoring its adverse prognostic impact.